-- New data showed setmelanotide achieved consistent, meaningful weight reduction -- -- Multiple presentations delivered at the first-ever Joint Congress between the European Society for Paediatric Endocrinology and the European Society of Endocrinology (ESPE-ESE); 32nd annual European Congress on Obesity (ECO); and the 2025 annual meeting of the Pediatric Endocrine Society (PES 2025) -- BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharm ...

VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- LEEF Brands Inc. (CSE: LEEF) (OTCQB: LEEEF) (“LEEF” or the “Company”), one of California’s premier vertical extraction companies, today announced a Management Services Agreement (“MSA”) with Glass House Brands, Inc. (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), a leading vertically integrated cannabis operator in the United States. Under the MSA, Glass House will manage operations of LEEF’s Palm Desert, California, dispe ...

LONG BEACH, Calif. and TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF) – one of the fastest-growing, vertically integrated cannabis companies in the United States, and LEEF Brands, Inc. (CSE: LEEF) (OTCQB: LEEEF), one of California’s premier vertical extraction companies, today announced a Management Services Agreement (“MSA”). Under the MSA, Glass House will manage operation of LEEF’s Pa ...

DUBAI, United Arab Emirates, May 14, 2025 (GLOBE NEWSWIRE) -- Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative satellite operators, and Arab Satellite Communications Organization (Arabsat), the top satellite service provider in the Arab world, today announced the companies have successfully negotiated and signed a Term Sheet for a multi-Gbps capacity pool of Telesat Lightspeed connectivity services. The companies executed the agreement today during a signing ceremony at the CAB ...

First quarter 2025 GAAP net income of $4.1 million or $0.18 per basic weighted average common share and Distributable Earnings(1)  of $4.5 million or $0.21 per basic weighted average common share WEST PALM BEACH, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- Advanced Flower Capital Inc. (Nasdaq: AFCG) (“Advanced Flower Capital”, “AFC” or the “Company”) today announced its results for the quarter ended March 31, 2025. AFC reported generally accepted accounting principles (“GAAP”) net income of $4.1 million or $0.18 ...

GAITHERSBURG, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of its executive management team will participate in the following investor conferences: RBC Global Healthcare Conference (New York, New York)Fireside chat on Tuesday, May 20 at 3:35 pm ETVirtual attendees can participate via webcast Goldman Sachs Leveraged Finance Conference, May 29, 2025 (Dana Point, California) Benchmark’s 5th Annual Healthcare House Call Virtual Investor ConferencePres ...

Generated record Q1 Contribution ex-TAC and programmatic revenue, driven by 40% year-over-year CTV revenue growth, alongside a 95% year-over-year increase in Adjusted EBITDA Trading structure simplification has driven higher trading volume as well as increased analyst and investor interest Completed $50 million Ordinary Share repurchase program and launched a new and ongoing $50 million repurchase program in April 2025 Hosting investor day on May 22, 2025 NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Nexxen ...

HALIFAX, Nova Scotia, May 14, 2025 (GLOBE NEWSWIRE) -- Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) ("Erdene" or the "Company") is pleased to announce operating and financial results for the quarter ended March 31, 2025, and to provide an update on progress at the Bayan Khundii Gold Project (“BK” or “Project”), being developed with Mongolian Mining Corporation (“MMC”). This release should be read in conjunction with the Company’s Q1 2025 Financial Statements and MD&A, available on the Company’s web ...

Enrollment and dosing underway in Phase 3 clinical trial (the “MIRACLE” trial) evaluating Annamycin (naxtarubicin) for the treatment of R/R AML Regulatory and site selection progress to date supports interim data readout expected in the second half of 2025 Recently received European Medicines Agency (EMA) approval adds nine additional countries to the Company’s ongoing MIRACLE trial; Authorization granted in all EU countries requested Company to host conference call and webcast today, May 14th at 8:30 AM E ...

VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) announces that the British Columbia Securities Commission (the "BCSC"), as the principal regulator of the Company, issued a cease trade order ("CTO") against the Company on May 7th, 2025 for the Company's failure to file its audited annual financial statements, accompanying management discussion and analysis and certifications for the financial year ended D ...